Reduce falls by improving balance
- Trial ID
- NCT06508801
- Official Title
- Blood Flow Restriction for Optimizing Balance in Parkinson's Disease
- Goal
- Reduce falls by improving balance
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- The University of Texas Health Science Center at San Antonio
- Study Type
- INTERVENTIONAL
- Enrollment
- 20 participants
- Conditions
- Parkinson's Disease and Parkinsonism
- Interventions
- Blood flow restriction training, Instability Resistance Training
Plain-Language Summary
The goal is to improve balance and lower fall risk in people with Parkinson's by strengthening the muscles and retraining balance reactions. The approach pairs blood flow restriction training, where a cuff around the upper leg partially limits blood flow during low-load exercises to boost metabolic stress and muscle gains without heavy weights, with instability resistance training that challenges balance on unstable surfaces to improve reactive control. This is an exercise technique to add to, not replace, your usual Parkinson's treatments. The trial is looking for adults 40 to 85 in Hoehn and Yahr stages 2 to 4 with a Mini‑Mental State Exam score of 23 or higher, who do not have serious heart or vascular problems, uncontrolled high blood pressure, recent lower-limb surgery, history of blood clots, very high BMI, or pregnancy.
Locations
- University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Blood flow restriction training. The goal is to improve balance and lower fall risk in people with Parkinson's by strengthening the muscles and retraining balance reactions. The approach pairs blood flow restriction training, where a cuff around the upper leg partially limits blood flow during low-load exercises to boost metabolic stress and muscle gains without heavy weights, with instability resistance training that challenges balance on unstable surfaces to improve reactive control. This is an exercise technique to add to, not replace, your usual Parkinson's treatments. The trial is looking for adults 40 to 85 in Hoehn and Yahr stages 2 to 4 with a Mini‑Mental State Exam score of 23 or higher, who do not have serious heart or vascular problems, uncontrolled high blood pressure, recent lower-limb surgery, history of blood clots, very high BMI, or pregnancy.
- Who can participate?
- Participants must be between 40 Years and 85 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 11 months.